Tamar Thompson is Director of Avidity Biosciences, Inc.. Currently has a direct ownership of 0 shares of RNA, which is worth approximately $0. The most recent transaction as insider was on Oct 07, 2024, when has been sold 30,000 shares (Common Stock) at a price of $44.98 per share, resulting in proceeds of $1,349,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held $0

Tamar Thompson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 07 2024
SELL
Open market or private sale
$1,349,400 $44.98 p/Share
30,000 Reduced 100.0%
0 Common Stock
Oct 07 2024
BUY
Exercise of conversion of derivative security
$828,900 $27.63 p/Share
30,000 Added 50.0%
30,000 Common Stock

Also insider at

CPRX
CATALYST PHARMACEUTICALS, INC. Healthcare
TT

Tamar Thompson

Director
San Diego, CA

Track Institutional and Insider Activities on RNA

Follow Avidity Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNA shares.

Notify only if

Insider Trading

Get notified when an Avidity Biosciences, Inc. insider buys or sells RNA shares.

Notify only if

News

Receive news related to Avidity Biosciences, Inc.

Track Activities on RNA